Proxy Voting Records Glossary

Fidelity Advisor Biotechnology Fund For the 12 month period: Jul 1, 2007 and Jun 30, 2008 ACORDA THERAPEUTICS, INC. Meeting Type: Annual Ticker: ACOR Security ID: 00484M106 Meeting Date: May 21, 2008 Proposed by: Management Back to Meetings # Proposal Management Recommendation Vote 1.1 ELECT RON COHEN, M.D. AS A DIRECTOR For For 1.2 ELECT LORIN J. RANDALL AS A DIRECTOR For For 1.3 ELECT STEVEN M. RAUSCHER AS A DIRECTOR For For 2 TO RATIFY THE APPOINTMENT OF KPMG LLP AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. For For 3 TO TRANSACT SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENT THEREOF. For Against     Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. © Copyright 1998-2009 FMR LLC. All rights reserved. Terms of Use  Privacy  Security  Site Map